Reporter covering health tech for Endpoints News. Formerly Business Insider and Modern Healthcare. Charleston native, Clemson alum. Go Tigers! https://bsky.app/profile/shelbylivingston.bsky.socialhttps://bsky.app/profile/shelbylivingston.bsky.social/post/3lt2xop2vlc2pWearables for everyone? I dug into the evidence behind the health tools RFK wants all Americans to use. https://endpoints.news/the-trump-administration-is-promoting-wearable-health-devices-with-or-without-evidence/03 Jul 2025 14:44 +0000at://did:plc:vbltrg4dbly6acgnlipsb2pg/app.bsky.feed.post/3lt2xop2vlc2phttps://bsky.app/profile/shelbylivingston.bsky.social/post/3lpmbdycd2k2uScoop! Calibrate has replaced its CEO and made several other executive changes, the latest leadership reset at the once high-flying weight loss company. https://endpts.com/weight-loss-startup-calibrate-replaces-ceo-in-leadership-shakeup/20 May 2025 14:11 +0000at://did:plc:vbltrg4dbly6acgnlipsb2pg/app.bsky.feed.post/3lpmbdycd2k2uhttps://bsky.app/profile/shelbylivingston.bsky.social/post/3lp7onqk2i22iNEW: Empower Pharmacy, which calls itself the US’ “largest and most advanced” compounding pharmacy, has used poor-quality ingredients, skirted regulations and pushed out or sued employees who raised concerns, an Endpoints News investigation found. https://endpts.com/pharmacy-empower-allegedly-used-low-quality-ingredients-skirted-rules/15 May 2025 14:05 +0000at://did:plc:vbltrg4dbly6acgnlipsb2pg/app.bsky.feed.post/3lp7onqk2i22ihttps://bsky.app/profile/shelbylivingston.bsky.social/post/3lnxgtfcegs2h$13 billion startup Devoted Health grew revenue to $3.3 billion in 2024 and shrank its operating losses, according to my analysis of state insurance filings. https://endpts.com/devoted-health-2024-financials-reveal-revenue-growth/29 Apr 2025 13:58 +0000at://did:plc:vbltrg4dbly6acgnlipsb2pg/app.bsky.feed.post/3lnxgtfcegs2hhttps://bsky.app/profile/shelbylivingston.bsky.social/post/3lksv3gr5ok2lAkido Labs is letting AI take the reins at the clinic, all the way from intake to diagnosis. "Our objective here is to pull the physician out of the room for as much time as we can, so that the physician can run many more visits in parallel," the CTO said. https://endpts.com/how-akido-labs-uses-ai-to-run-medical-visits-from-intake-to-diagnosis/20 Mar 2025 14:14 +0000at://did:plc:vbltrg4dbly6acgnlipsb2pg/app.bsky.feed.post/3lksv3gr5ok2lhttps://bsky.app/profile/shelbylivingston.bsky.social/post/3lkbayubauc2iI caught up with GoodRx's new CEO Wendy Barnes. “This platform should be valued considerably higher, given what we delivered historically and the plan that we’ve laid out for ‘25 and beyond. But we’ve got a job to do to school investors to help them to understand that.” https://endpts.com/goodrx-ceo-wendy-barnes-on-the-future-of-the-drug-discount-company/13 Mar 2025 14:00 +0000at://did:plc:vbltrg4dbly6acgnlipsb2pg/app.bsky.feed.post/3lkbayubauc2ihttps://bsky.app/profile/shelbylivingston.bsky.social/post/3lk7cbbggts23We won! [contains quote post or other embedded content]12 Mar 2025 19:17 +0000at://did:plc:vbltrg4dbly6acgnlipsb2pg/app.bsky.feed.post/3lk7cbbggts23https://bsky.app/profile/shelbylivingston.bsky.social/post/3liz3fizafk23No semaglutide shortage, no problem. Hims execs said Monday evening that its weight loss biz is projected to drive at least $725 million in revenue for the company this year — almost a third of the revenue Hims expects to pull in across the entire company. https://endpts.com/hims-eyes-growth-in-its-weight-loss-business-despite-end-of-semaglutide-shortage/25 Feb 2025 14:33 +0000at://did:plc:vbltrg4dbly6acgnlipsb2pg/app.bsky.feed.post/3liz3fizafk23https://bsky.app/profile/shelbylivingston.bsky.social/post/3lhyumdjiv227There's no quick fix to the problems plaguing CVS' health insurance biz. https://endpts.com/what-cvs-is-doing-about-high-medical-costs/12 Feb 2025 19:06 +0000at://did:plc:vbltrg4dbly6acgnlipsb2pg/app.bsky.feed.post/3lhyumdjiv227https://bsky.app/profile/shelbylivingston.bsky.social/post/3lhhgj5gxf227Competition from compounded GLP-1s is cutting into demand for Novo Nordisk’s prescriptions. "Our latest market intelligence does tell us and show us that it is having an impact and it is growing faster than we had anticipated,” a Novo exec said Wednesday. https://endpts.com/novo-nordisk-is-feeling-the-competition-from-compounded-glp-1s-exec-says/05 Feb 2025 20:39 +0000at://did:plc:vbltrg4dbly6acgnlipsb2pg/app.bsky.feed.post/3lhhgj5gxf227https://bsky.app/profile/shelbylivingston.bsky.social/post/3lfuriykuxc2sSince the killing of UnitedHealth's top insurance exec and the subsequent outpouring of public frustration with delayed and denied care, a major question has circled the giant: Will it change how it does business? So far, there’s little sign big reforms are in the works. https://endpts.com/unitedhealth-group-reports-higher-revenue-in-first-earnings-since-brian-thompsons-murder/16 Jan 2025 17:10 +0000at://did:plc:vbltrg4dbly6acgnlipsb2pg/app.bsky.feed.post/3lfuriykuxc2shttps://bsky.app/profile/shelbylivingston.bsky.social/post/3lfpi2kukv224I got the rundown from Swati Mathai, longtime Elevance Health exec, about her new health plan startup XO Health. https://endpts.com/xo-health-launches-as-alternative-health-plans-catch-on/14 Jan 2025 14:37 +0000at://did:plc:vbltrg4dbly6acgnlipsb2pg/app.bsky.feed.post/3lfpi2kukv224https://bsky.app/profile/shelbylivingston.bsky.social/post/3ldo7v5oavc2rTirzepatide shortage is over, says FDA. That means compounding pharmacies making lots of copies of brand-name Zepbound and Mounjaro have to stop soon. https://endpts.com/in-blow-to-compounders-fda-reaffirms-tirzepatide-shortage-is-over/19 Dec 2024 15:48 +0000at://did:plc:vbltrg4dbly6acgnlipsb2pg/app.bsky.feed.post/3ldo7v5oavc2rhttps://bsky.app/profile/shelbylivingston.bsky.social/post/3ldjlz54qks2aNew: While “prescribing” food is far from the norm, the next administration could change that. Some startups in the food-as-medicine space are already fielding calls from interested investors. From me and @lydiapflanzer.bsky.social https://endpts.com/food-as-medicine-could-get-boost-from-trump-presidency/17 Dec 2024 19:42 +0000at://did:plc:vbltrg4dbly6acgnlipsb2pg/app.bsky.feed.post/3ldjlz54qks2ahttps://bsky.app/profile/shelbylivingston.bsky.social/post/3ld4rkrcgyc25A good one from @tradeoffs.bsky.social @dgorenstein.bsky.social https://tradeoffs.org/2024/12/12/health-insurer-blame-aaron-carroll/12 Dec 2024 17:16 +0000at://did:plc:vbltrg4dbly6acgnlipsb2pg/app.bsky.feed.post/3ld4rkrcgyc25https://bsky.app/profile/shelbylivingston.bsky.social/post/3lczypiumfc2zWhen you keep your enemies close... Eli Lilly and Ro have formed an unlikely partnership, with Ro now offering cash-pay Zebpound vials through its app. Recall that Ro has offered compounded GLP-1 drugs, which Lilly and Novo have railed against. https://endpts.com/eli-lilly-has-tapped-telehealth-startup-ro-to-distribute-its-single-dose-zepbound-vials/11 Dec 2024 14:46 +0000at://did:plc:vbltrg4dbly6acgnlipsb2pg/app.bsky.feed.post/3lczypiumfc2zhttps://bsky.app/profile/shelbylivingston.bsky.social/post/3lclkdxjnzs26My latest: The killing of UnitedHealthcare's CEO has highlighted the threats increasingly faced by healthcare execs and prompted companies to rethink how they keep their top brass safe. “This is a huge wake-up call,” the head of exec protection at Allied Universal said. https://endpts.com/health-execs-security-in-spotlight-after-unitedhealthcare-ceo-killing/05 Dec 2024 20:52 +0000at://did:plc:vbltrg4dbly6acgnlipsb2pg/app.bsky.feed.post/3lclkdxjnzs26